BACKGROUNDThe citrus red mite, Panonychus citri (McGregor), a global pest of citrus, has developed different levels of resistance to various acaricides in the field. Abamectin is one of the most important insecticides/acaricides worldwide that target a wide number of insect and mite pests. The evolution of abamectin resistance in P. citri is threatening the sustainable use of abamectin for mite control.RESULTSThe abamectin resistant strain (NN‐Aba), derived from a field strain NN by consistent selection with abamectin, showed 4,279‐fold resistance to abamectin compared to a relatively susceptible strain (SS) of P. citri. Cross‐resistance of NN‐Aba was observed between abamectin and emamectin benzoate, pyridaben, fenpropathrin, as well as cyflumetofen. Inheritance analyses indicated that abamectin resistance in the NN‐Aba strain was autosomal, incompletely recessive and polygenic. The synergy experiment showed that abamectin toxicity was synergized by piperonyl butoxide (PBO), diethyl maleate (DEM), and tributyl phosphorotrithiotate (TPP) in the NN‐Aba strain, and synergy ratios were 2.72‐, 2.48‐, and 2.13‐fold, respectively. The glutathione S‐transferases activity in the NN‐Aba strain were significantly increased by 2.08‐fold compared with the NN strain.CONCLUSIONThe abamectin resistance was autosomal, incompletely recessive and polygenic in P. citri. The NN‐Aba strain showed cross‐resistance to various acaricides with different modes of action. Metabolic detoxification mechanism participated in abamectin resistance in NN‐Aba strain. These findings provide useful information for resistance management of P. citri in the field.This article is protected by copyright. All rights reserved.